Popular weight loss drug raises risk of ‘silent’ cancer – study 

New research has indicated a 33% higher incidence of kidney cancer among Ozempic users compared to non-users

Ozempic and similar weight loss medications may increase the risk of kidney cancer, according to a major study. However, the drugs reportedly lower the risk of more than a dozen other cancers, suggesting their overall benefit may still outweigh the hazards.    

A recent study presented at the American Society of Clinical Oncology’s...